Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.

Journal of chemotherapy (Florence, Italy) - 1 Aug 1996

Blahová J, Lesická-Hupková M, Králiková K, Krcméry V, Mikovicová A

Abstract excerpt

Although strains of Enterobacter sp. produce a chromosomal AmpC beta-lactamase, they have been, in general, susceptible to cefotaxime or ceftazidime. But now resistance to ceftazidime has increased in nosocomial Enterobacter strains, reaching the level of 40%. A chromosomal mutation in the amp operon coding the production of AmpC type beta-lactamase may cause a change in the conversion of a susceptible strain of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Proteins
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cefotaxime

Share to Conjugation, Genetic

Share to Drug Resistance, Microbial

Share to Mutation

Share to Operon

Share to Selection, Genetic

Source

Identifiers

PMID: 8873831
DOI: 10.1179/joc.1996.8.4.266

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.PMID 8873831Read ↗

Progression of ampC amplification during de novo amoxicillin resistance development in E. coli.Semantic proximity Read ↗

Complex Regulation Pathways of AmpC-Mediated β-Lactam Resistance in Enterobacter cloacae Complex.Semantic proximity Read ↗

Genetic control of beta-lactamase production in Enterobacter cloacae.Semantic proximity Read ↗

Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenemSemantic proximity Read ↗

Hitchhiking genes and boundaries of AmpC amplicons during amoxicillin resistance development in E. coli.Semantic proximity Read ↗

Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamaseSemantic proximity Read ↗

Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae.Semantic proximity Read ↗

The differential importance of mutations within AmpD in cephalosporin resistance of Enterobacter aerogenes and Enterobacter cloacae.Semantic proximity Read ↗

Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR.Semantic proximity Read ↗

An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection.Semantic proximity Read ↗

ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae.Semantic proximity Read ↗

Chromosomal system for studying AmpC-mediated beta-lactam resistance mutation in Escherichia coli.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.